Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-14-013014
Filing Date
2014-04-01
Accepted
2014-04-01 10:37:51
Documents
1
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4889
  Complete submission text file 0001127602-14-013014.txt   6277
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
ABERCROMBIE GEORGE B (Reporting) CIK: 0001485939 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 14732657